Diabetes regression and remission following a short-term intensive metabolic intervention with insulin glargine, metformin and dapagliflozin

被引：0
|
作者：
McInnes, N. [1 ,2 ]
Hall, S. [1 ]
Liu, Y. Y. [1 ]
Gerstein, H. C. [1 ,2 ]
机构：
[1] Populat Hlth Res Inst, Hamilton, ON, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON, Canada
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
748
引用
收藏
页码：S360 / S361
页数：2
相关论文
共 50 条
  • [1] Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin
    McInnes, Natalia
    Hall, Stephanie
    Sultan, Farah
    Aronson, Ronnie
    Hramiak, Irene
    Harris, Stewart
    Sigal, Ronald J.
    Woo, Vincent
    Liu, Yan Yun
    Gerstein, Hertzel C.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (08): : 2532 - 2540
  • [2] Predictors of Remission of Type 2 Diabetes following a Short-Term Intensive Metabolic Intervention
    Mcinnes, Natalia
    Smith, Ada
    Punthakee, Zubin
    Sherifali, Diana
    Balasubramanian, Kumar
    Hall, Stephanie
    Gerstein, Hertzel C.
    DIABETES, 2015, 64 : A437 - A438
  • [3] Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial
    McInnes, Natalia
    Hall, Stephanie
    Hramiak, Irene
    Sigal, Ronald J.
    Goldenberg, Ronald
    Gupta, Nikhil
    Rabasa-Lhoret, Remi
    Braga, Manoela
    Woo, Vincent
    Sultan, Farah
    Otto, Rose
    Smith, Ada
    Sherifali, Diana
    Liu, Yan Yun
    Gerstein, Hertzel C.
    DIABETES CARE, 2022, 45 (01) : 178 - 185
  • [4] Remission of type 2 diabetes following a short-term intervention with insulin glargine and metformin/sitagliptin: results of the REMIT-sita randomised controlled trial
    Gerstein, H.
    Hall, S.
    Hramiak, I.
    Sigal, R. J.
    Goldenberg, R.
    Gupta, N.
    Rabasa-Lhoret, R.
    Braga, M.
    Woo, V.
    Sultan, F.
    Otto, R.
    Smith, A.
    Sherifali, D.
    Liu, Y. Y.
    McInnes, N.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 223 - 224
  • [5] Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial
    McInnes, Natalia
    Hall, Stephanie A.
    Lochnan, Heather A. B.
    Harris, Stewart B.
    Punthakee, Zubin J.
    Sigal, Ronald J.
    Hramiak, Irene
    Azharuddin, Mohammed F.
    Liutkus, Joanne F.
    Yale, Jean-Francois
    Sultan, Farah
    Smith, Ada E.
    Otto, Rose E.
    Sherifali, Diana
    Liu, Yan Yun C.
    Gerstein, Hertzel C.
    DIABETES OBESITY & METABOLISM, 2023, 25 (11): : 3347 - 3355
  • [6] Predictors of Drug-Free Diabetes Remission over 48 Weeks following Short-Term Intensive Insulin Therapy (IIT)
    Kramer, Caroline K.
    Zinman, Bernard
    Choi, Haysook
    Retnakaran, Ravi
    DIABETES, 2016, 65 : A242 - A243
  • [7] IMPROVEMENT AND REGRESSION IN STUTTERERS FOLLOWING SHORT-TERM INTENSIVE THERAPY
    PRINS, D
    JOURNAL OF SPEECH AND HEARING DISORDERS, 1970, 35 (02): : 123 - 135
  • [8] Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial
    Mcinnes, Natalia
    Hall, Stephanie
    Lochnan, Heather A.
    Harris, Stewart B.
    Punthakee, Zubin
    Sigal, Ronald J.
    Hramiak, Irene
    Azharuddin, Mohammed
    Liutkus, Joanne F.
    Yale, Jean-Francois
    Sultan, Farah
    Smith, Ada C.
    Otto, Rose E.
    Sherifali, Diana
    Liu, Yan Yun
    Gerstein, Hertzel C.
    DIABETES, 2021, 70
  • [9] Remission of type 2 diabetes following intensive treatment with insulin glargine/lixisenatide, metformin and lifestyle approaches: results of the REMIT-iGlarLixi trial
    McInnes, N.
    Hall, S.
    Lochnan, H.
    Harris, S.
    Punthakee, Z.
    Sigal, R. J.
    Hramiak, I.
    Azharuddin, M.
    Liutkus, J.
    Yale, J. -F.
    Sultan, F.
    Smith, A.
    Sherifali, D.
    Liu, Y. Y.
    Gerstein, H.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 224 - 224
  • [10] The efficacy of metformin-based OAD is not inferior to insulin glargine in newly diagnosed type 2 diabetes mellitus patients with severe hyperglycaemia after short-term intensive insulin therapy
    Shumin, Y.
    Cheng, Q.
    Zhao, C.
    Ye, P.
    Li, Q.
    Liu, Z.
    DIABETOLOGIA, 2013, 56 : S106 - S107
12345